Skip to main content

Table 2 Prevalence of anti-CarP, ACPA and RF in patients with RA, disease controls and healthy subjects

From: Prevalence, sensitivity and specificity of antibodies against carbamylated proteins in a monocentric cohort of patients with rheumatoid arthritis and other autoimmune rheumatic diseases

Disease (number of patients)

Anti-CarP positive, n, (%)

ACPA positive, n, (%)

RF positive, n, (%)

RA (309)

117 (34.4)

190 (61.4)

202 (65.3)

NHS (98)

2 (2.04)

1 (1.02)

3 (3.06)

SLE (83)

14 (16.8)

15 (18.07)

19 (22.8)

SS (45)

14 (31.1)

11 (24.4)

23 (51.1)

SSc (51)

3 (5.8)

1 (1.9)

18 (35.2)

OP (21)

2 (9.5)

2 (9.5)

4 (19.04)

  1. Anti-CarP anti-carbamylated proteins antibodies, ACPA anti-citrullinated peptides antibodies, RF rheumatoid factor, RA rheumatoid arthritis, NHS normal healthy subjects, SLE systemic lupus erythematosus, SS Sjögren syndrome, SSc systemic sclerosis, OP osteoporosis